Upsher-Smith Announces Milestone In Development Of CNS Strategy
USL255 (Extended Release Topiramate) Entering Late-Stage Clinical Development for Epilepsy
09:19AM 12/03/09
Par Pharmaceutical Announces Results Of Its 'Modified Dutch Auction' Tender Offer
09:00AM 11/25/09
Biotech Stock Mailbag: Cardium Therapeutics
The fall in Cardium shares might be related, at least partially, to what looks like so-so results from a phase IIb study announced on Oct. 14.
01:01PM 11/13/09
Biotech Stock Mailbag: Cardium Therapeutics
The fall in Cardium shares might be related, at least partially, to what looks like so-so results from a phase IIb study announced on Oct. 14.
07:31AM 11/13/09
Biotech Stock Mailbag: Cardium Therapeutics (RealMoney.com $)
The fall in Cardium shares might be related, at least partially, to what looks like so-so results from the phase IIb study announced on Oct. 14.
05:00AM 11/13/09
Par 3Q Profit Surges On Product Sales
Par Pharmaceutical profit jumps, revenue nearly doubles
09:49AM 11/06/09
Morning Playbook: Dividend.com
Goldman Sachs, Southwest Airlines and Harley are among today's story stocks.
10:13AM 10/15/09
Further Volume Slides Ahead (The Daily Swing Trade $)
Volume should drop like a rock as we get closer to Labor Day, undermining the predictive capacity of price patterns.
06:01PM 08/25/09
Par Pharma Edges Higher To Finish Weekly Gains
Par ticks up, having gained 14 percent on Ultram patent ruling and generic Catapres approval
02:05PM 08/21/09
Linn Energy Chairman Sells $8.8M Worth
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
10:28AM 08/20/09
Premarket Roundup: Par Pharma, Analog Devices
Premarket roundup: Par Pharma up after FDA approves patch, Analog Devices drops on 3Q results
09:27AM 08/19/09
Ahead Of The Bell: Par Pharma Continues To Rise
Par Pharma rises as FDA approves blood pressure patch a day after Ultram ER patent ruling
09:11AM 08/19/09
Par Claims Patent Win In Dispute Over Pain Drug
Par Pharmaceutical cites favorable ruling in patent dispute over pain drug Ultram ER
10:18AM 08/17/09
Speculating on Spectrum (RealMoney.com $)
Spectrum Pharmaceuticals' revenue-generating products look attractive to larger specialty drug companies.
12:23PM 07/31/09



Connect with TheStreet